Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis)

About this episode

This episode discusses a 2024 post hoc analysis of early onset type 2 diabetes and the drug Tirzepatide as published in Diabetes Care.

In this episode of Hormone Insight, we examine a 2024 post hoc analysis published in Diabetes Care.

Topics covered

• Type 2 Diabetes
• Tirzepatide
• Post Hoc Analysis
• Diabetes Care
• Health Education

Keywords

• Type 2 Diabetes
• Tirzepatide
• post hoc analysis
• Diabetes Care
• 2024

Mentioned in this episode

Organizations: Diabetes Care

Products: Tirzepatide

More episodes of Hormone Insight

• The Week in Endocrinology Oral Ozempic & Emerging Therapies · May 12, 2026 · 5 min
• Week in Diabetes & Endocrinology (May 4, 2026): AID in Pregnancy, Tirzepatide ICERs, AACE Signals, Dapagliflozin & Anemia, Hypoglycemia Models, Oat Diet Trial · May 5, 2026 · 16 min
• HORMONE INSIGHT -- THE WEEK IN DIABETES & ENDOCRINOLOGY -- Episode 004 | April 24, 2026 · April 24, 2026 · 14 min
• The Week in Diabetes and Endocrinology April 17, 2026 · April 22, 2026 · 18 min
• Episode 002: LDL Under 55 Wins Big, Medicare Covers GLP-1, and Second Weekly Insulin Emerges -- The Week in Diabetes & Endocrinology (April 10, 2026) · April 9, 2026 · 17 min
• The Week in Diabetes and Endocrinology -- April 3, 2026 · April 5, 2026 · 24 min